Resmed (RSMDF) Net Cash Flow (2009 - 2026)

Resmed has reported Net Cash Flow for 18 years, with the latest figure at $240.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 40.2% year-over-year to $240.9 million; the trailing twelve-month figure through Mar 2026 stood at $687.0 million (down 2.48% YoY), and the FY2025 full-year result was $945.3 million, up 7655.27% from the prior year.
• Net Cash Flow for Q1 2026 stood at $240.9 million, up from $30.5 million in the prior quarter.
• The five-year high for Net Cash Flow was $402.8 million in Q1 2025, with the low at -$56.0 million in Q3 2022.
• Historically, Net Cash Flow has averaged $85.2 million across 5 years, with a median of $33.0 million in 2024.
• Annual changes were most pronounced in 2023 — Net Cash Flow slumped 454.16% — and 2025, when it surged 74796.27%.
• Resmed's Net Cash Flow stood at $35.1 million in 2022, then slumped by 120.69% to -$7.3 million in 2023, then jumped by 1811.28% to $124.4 million in 2024, then plunged by 75.52% to $30.5 million in 2025, then soared by 690.9% to $240.9 million in 2026.
• The last three Net Cash Flow figures came in at $240.9 million (Q1 2026), $30.5 million (Q4 2025), and $174.5 million (Q3 2025), per Business Quant data.